All News

ANCA, vasculitis, test

Avacopan for ANCA Vasculitis Goes in Front of the FDA

d MedPage Today

An FDA advisory panel will consider whether to recommend approval of an oral C5a inhibitor for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, with agency staff raising questions over the "clinical meaningfulness" of key study data.

Read Article
RheumNow Podcast square

RheumNow Podcast – Falling or Falling in Love?

d Jack Cush, MD

Dr. Jack Cush reviews the best journal articles from the past week on RheumNow.com.

Read Article
microbio2.jpg

Unique Oral Microbiome in Early and Pre-Clinical RA

d Jack Cush, MD

An oral microbiome study of rheumatoid arthritis patients suggests that periodontal condition in patients with early rheumatoid arthritis and individuals at risk of RA.

Read Article
News Feature: Unique Oral Microbiome in Early and Pre-Clinical RA An oral microbiome study of rheumatoid arthritis (RA) patients suggests that periodontal condition in patients with early rheumatoid arthritis (ERA) and individuals at risk of RA. https://t.co/r3kT52MByC https://t.co/MocZ6PXZzA

Links:

Dr. John Cush RheumNow ( View Tweet)
Have you listened to the latest RheumNow podcast? Falling or Falling in Love https://t.co/SmPCqKpXLY https://t.co/LQSsGJCY9u

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Avacopan for ANCA Vasculitis Goes in Front of the FDA An FDA advisory panel will consider whether to recommend approval of an oral C5a inhibitor for ANCA-associated vasculitis. https://t.co/66NSjbkE8Q https://t.co/9cR2lBASjz

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Kathryn Dao - Risk of Hydroxychloroquine Retinal Toxicity From ACR 2020 https://t.co/7BCVvMOm0T https://t.co/PhHubO7rxG

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: ARTIC REWIND - Don't Half DMARD Therapy https://t.co/mZFehDM9nf https://t.co/QQ8IhMYUjk

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Janet Pope - Belimumab in SLE nephritis From ACR 2020 https://t.co/ZoMslbX5dF https://t.co/xnKXXRJ6wE

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Michelle Petri - Best Practices in Testing for Antiphospholipid Syndrome (LAC wins) From ACR 2020 https://t.co/IyeRDzw4BC https://t.co/nSkauHf29T

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast alert! Falling or Falling in Love (5.7.2021) Dr Jack Cush reviews the best journal articles of the week from RheumNow https://t.co/HyAPN2rM3L https://t.co/C5XtqthO8I

Links:

Dr. John Cush RheumNow ( View Tweet)
May is also arthritis awareness month! Why we love Rheumatology Fellows https://t.co/rNVjZZr9l4 #ArthritisAwarenessMonth

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Drug Monitoring Ineffective with Infliximab Treatment A randomized trial compared TDM to no TDM in patients receiving infliximab for chronic IMIDs and found that TDM did not increase the odds of achieving remission. https://t.co/AVcX4EXY0l https://t.co/RlDij6ln61

Links:

Dr. John Cush RheumNow ( View Tweet)
Falls are not uncommon in #RA patients; significant risk factors for falls include being elderly, un-married, higher pain scores, reported dizziness taking psychotropic medications and having lower HRQoL scores https://t.co/a8qA7n68q5

Links:

Dr. John Cush RheumNow ( View Tweet)

Today begins National Nurses week! God Bless Rheumatology Nurses https://t.co/JC9ExqnXEb #ArthritisAwarenessMonth https://t.co/bhuocIlHWT

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Childhood Lupus May Hamper Adult Careers Long-term outcomes of kids with cSLE are uncommon, but this cSLE cohort analysis suggests that SLE significantly impacts their future education, vocation, and employment as they reach adulthood. https://t.co/RQc4JD3BIt https://t.co/l0ZQWHNFng

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Kathryn Dao - Pregnancy Outcomes in Lupus, SpA From ACR 2020 https://t.co/TvlqwZqgOv https://t.co/UBeVghYh0g

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us each Tuesday for Tuesday Night Rheumatology. We'll have new speakers each week and a Q&A session available following the discussion. https://t.co/ugGaPvBsLD https://t.co/CCua5Uvl7f

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of healthcare resource utilization and costs psoriasis, psoriatic arthritis (PsA) vs controls; PsA has the highest annual all-cause healthcare costs per patient - Controls =$7,470, Psoriasis= $11,062, and PsA = $29,742 https://t.co/06irRupcLJ

Links:

Dr. John Cush RheumNow ( View Tweet)

Systematic review 6 studies of ischemic stroke and Idiopathic inflammatory myopathies (IIM) shows among 5,114 IIM cases there was an increased risk of ischemic stroke (RR = 2.41, 95% CI: 1.31, 4.45), 49% higher in dermatomyositis and Asian IIM. https://t.co/gYdMgmU5Uh

Links:

Dr. John Cush RheumNow ( View Tweet)

×